The DNA Methylation Detection Kit for Human ASTN1、DLX1、ITGA4、RXFP3、SOX17、ZNF671 Gene (Cervical Cancer) qualitatively detects the methylation status of 6 genes in human cervical exhumation cells in vitro to evaluate whether the abnormal population with preliminary screening results has the risk of cancer, and distinguish the population with high probability of self-healing and high risk of cancer. So as to carry out triage management, avoid excessive diagnosis and treatment, truly achieve individualized and precision medicine, reduce the physiological, psychological and economic burdens of patients, and optimize the allocation of medical resources.

Pneumocystis jirovecii (P. jirovecii) is an opportunistic pathogenic bacterium that lives in the lungs. Tumors, etc., can cause Pneumocystis pneumonia (PCP). The clinical manifestations of PCP are non-specific. Most patients present with fever as the first symptom, followed by symptoms such as chest tightness, shortness of breath, dry cough with less sputum, and dyspnea. The progression is rapid and the mortality rate is high.

This is a nucleic acid contamination scavenger that provides a total solution for laboratory contamination.

The Mucoraceae detection kit is based on real-time polymerase chain reaction (PCR) technology and consists of ready-to-use optimized reaction solutions, specific primers and fluorescent probes.

The Aspergillus series kit consists of an optimized mix of target-specific primers and probes for the detection of Aspergillus fungi and the identification of genetic mutations associated with polyazole resistance. Based on multiplex PCR technology, the kit uses fluorescent probes and melting curves to identify the tandem repeat sequence TR34 and SNP sites L98H, T289A and Y121F in the CYP51A gene of Aspergillus fumigatus, thereby distinguishing wild-type and drug-resistant strains.

This kit is based on multiplex fluorescent PCR technology, which is realized by fluorescent probes in the mixture. Amplification and melting curve analysis are performed on a real-time fluorescent PCR instrument, and fluorescence in green, yellow, orange and red channels can be detected.

This kit is used for in vitro qualitative detection of monkeypox virus F3L gene in serum samples, exudates from lesions or respiratory tract swab samples (oropharyngeal swab and nasopharyngeal swab) of suspected monkeypox cases or other cases that require monkeypox virus infection diagnosis or differential diagnosis.

The reagent kit can simultaneously detect the nucleic acid of ten pathogens of urinary and reproductive system infections, quickly and effectively identify the pathogen species of patients with urinary and reproductive system infections. Combined with other clinical and epidemiological information, it will help diagnose urinary and reproductive system infections.

The GastroFinder® 2SMART test kit is a test kit that uses SmartFinder® technology for testing. This technology can detect and analyze as much as 30 target genes in one PCR reaction. This test kit first performs reverse transcription amplification to produce cDNA, then divides the reverse transcription product into two parts to carry out two independent 2SMART reactions. The identification method is melting curve analysis.

Meningitis and encephalitis infections are caused by viral, bacterial or fungal infections. The onset is rapid, progresses quickly, and has a high mortality and disability rate. Early diagnosis is of great significance for treatment and prognosis. Traditional cerebrospinal fluid routine, biochemical, staining and culture examinations have shortcomings in diagnostic sensitivity and specificity, which brings difficulties to early diagnosis and differential diagnosis of diseases. This test kit is based on multiplex PCR technology and can qualitatively detect and distinguish the nucleic acids of 22 meningitis pathogens that cause meningitis and encephalitis in the human body within 2.5 hours.

The respiratory pathogen detection kit is based on single-tube multiplex PCR technology, which can detect up to 13 target genes simultaneously in a single PCR. The kit begins with a first-step PCR reaction, which consists of reverse transcription amplification to synthesize a cDNA, followed by dilution of the first-step PCR product, taking a portion of the product and splitting it into two separate second-step PCR reactions. The melting curve was used for analysis.

Certifications: CE certification, Philippines, and Thailand FDA certification, Import License of UAE

The kit uses the colloidal gold method of immunochromatography, with a specific antibody targeting the SARS-CoV-2 N protein antigen. This product utilize highly specific virus antibodies to detect related specific virus antigens

This product uses a competitive ELISA method for testing. The sample to be tested and the control sample are pre-incubated with SARS-CoV-2 RBD protein to allow neutralizing antibodies to bind with RBD. The mixture is then added to a microplate with ACE2 pre-coated on it. Unbound RBD and RBD bound with non-neutralizing antibodies are captured on the microplate, while the neutralizing antibody-RBD complex remains in the supernatant and is removed during washing cycles. After washing, enzyme-labeled antibody is added and TMB substrate coloration follows. The OD value after the reaction is measured by an ELISA reader. The concentration of SARS-CoV-2 neutralizing antibodies in the sample is calculated from the OD value measured by an ELISA reader.

The 2019 novel coronavirus (2019-nCoV, named by the World Health Organization on January 12, 2020; SARS-CoV-2, named by the International Committee on Taxonomy of Viruses on February 11, 2020). Coronaviruses are a large family of viruses that can cause colds, Middle East respiratory syndrome (MERS), severe acute respiratory syndrome (SARS) or other serious diseases. The SARS-CoV-2 is a new species of coronavirus that has never been found in humans before. Common signs of infection include respiratory symptoms, fever, cough, shortness of breath and breathing difficulties. In some severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure or even death.

Nucleic acid extraction instrument is an instrument that automatically completes the nucleic acid extraction of samples by using the corresponding nucleic acid extraction reagent. Widely used in disease control centers, clinical disease diagnosis, blood transfusion safety, forensic identification, environmental microbiology detection, food safety detection, animal husbandry and molecular biology research and other fields.

Shanghai GeneoDx Medical Laboratory Co., Ltd. (GeneoDx Medical) was established in March 2022. It is a wholly-owned subsidiary of GeneoDx, and one of the key tasks of China National Biotech Group's planning and development.
GeneoDx Medical is beset with a professional examination team, advanced technology and top-notch equipments and facilities, including Sanger platform, multiplex PCR platform, digital PCR platform, immune platform and information analysis platform.  .
GeneoDx Medical features the detection of tumors and pathogenic microorganisms. By optimizing the allocation of health resources such as medical testing technology, equipment and personnel, it can help in the achievement of graded diagnosis and treatment, alleviation of the workload of medical institutions, decline of medical costs, and complement of diverse medical resources, so as to provide high-quality services to patients. The testing services provided are in the fields of sexually transmitted diseases, prenatal and postnatal care, respiratory pathogens, microbial drug resistance, fungi, oncology, etc.

Through cooperation with medical institutions and scientific research institutions, GeneoDx Medical deeply explores academic research related to diseases diagnosis/control and treatments, jointly applies for national, provincial, municipal and regional projects of Natural Science Foundation, and tracks and develops new technologies, new products and new services. For the continuous improvement of diagnostic technology and academic status of medical institutions at all levels in the region, it will relentlessly pursue its efforts to meet the needs of hospitals and scientific research institutes.

Since its establishment, GeneoDx Medical has established a quality management system in strict accordance with the requirements of ISO15189 and CAP to ensure the accuracy and stability of test results, promote mutual recognition of reports, regionalization of coverage and integration of basic data of laboratory management information collection to meet the needs of medical research, health administration and public health management.

GeneoDx Medical adheres to the corporate philosophy of "All for health, health for all", with independent R&D results and imported technology, is committed to the realization of "guarding life and health with scientific and technological power".

(1) Provide the design scheme of the structure, water and electricity facilities and regional layout of the medical laboratory;

(2) Provide the overall operation plan of medical nucleic acid laboratory, including main equipment list, personnel configuration, sampling workflow, nucleic acid testing workflow, quality control and logistics support;